REVELATION BIOSCIENCES, INC.

REVB · Nasdaq · SIC 2834: Pharmaceutical Preparations
157
SEC Filings

Business Summary

. Overview Revelation is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. We have multiple ongoing programs to evaluate Gemini, including GEM-AKI as a treatment for acute kidney injury (AKI) and GEM-CKD as a treatment for chronic kidney disease (CKD). The Company was incorporated in the state of Delaware on November 20, 2019 (originally as Petra Acquisition, Inc.) and is based in San Diego, California. ...

Next Earnings

Q2 FY2026 — expected 2026-09-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionREVBdiscussed_in_filing Cybersecurity
topic_mentionREVBdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076552EDGAR82K words
2025-03-062024-12-310000950170-25-034584EDGAR—
2024-03-222023-12-310000950170-24-035322EDGAR—
2023-03-302022-12-310000950170-23-011000EDGAR—
2022-04-152021-12-310001213900-22-020179EDGAR—
2021-03-312020-12-310001213900-21-019097EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-269450EDGAR18K words
2025-08-082025-06-300000950170-25-105284EDGAR—
2025-05-082025-03-310000950170-25-066897EDGAR—
2024-11-082024-09-300000950170-24-124036EDGAR—
2024-08-092024-06-300000950170-24-094727EDGAR—
2024-05-102024-03-310000950170-24-057787EDGAR—
2023-11-092023-09-300000950170-23-062025EDGAR—
2023-08-112023-06-300000950170-23-041851EDGAR—
2023-05-222023-03-310000950170-23-023313EDGAR—
2022-11-102022-09-300000950170-22-024436EDGAR—
2022-08-152022-06-300000950170-22-017405EDGAR—
2022-05-162022-03-310000950170-22-009906EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-190001193125-26-116012EDGAR1K words
2026-02-260001193125-26-076833EDGAR—
2026-01-290001193125-26-027742EDGAR—
2026-01-220001193125-26-018332EDGAR—
2025-12-030001193125-25-306915EDGAR—
2025-11-060001193125-25-269696EDGAR—
2025-10-290001193125-25-256367EDGAR—
2025-10-150001193125-25-240400EDGAR—
2025-09-150001193125-25-203750EDGAR—
2025-09-090001810560-25-000006EDGAR—

157 total filings indexed. 129 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001810560
TickerREVB
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 24aacb38b7ece98d877973e652794ca98ac4ca1c0d3cc7cb4910e28f8b76d4f2
parent: a9e4bc8bcdb52bc5500cd0527c9827296cb44f8594e4ecceba85f3e409333fd4
content hash: 32cd3dcc5c6c51a3e7c501b7bc9d5e0c3b0a71a4c0d894346b0d1137e4a7b163
signed: 2026-04-13T04:47:10.325Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf